The Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market is expected to witness market growth at a CAGR of 25% during the forecast period of 2022 to 2028. Tranthyretin amyloidosis (ATTR) is a rare, progressive and severe disease. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of transthyretin amyloidosis (ATTR) that affects the heart and causes restrictive cardiomyopathy […]
